TITLE

The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only-what is the clinical significance?

AUTHOR(S)
Meining, A.; Ott, R.; Becker, I.; Hahn, S.; Mühlen, J.; Werner, M.; Höfler, H.; Classen, M.; Heidwein, W.; Rösch, T.
PUB. DATE
October 2004
SOURCE
Gut;Oct2004, Vol. 53 Issue 10, p1402
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The incidence of distal oesophageal adenocarcinoma is rising, with chronic reflux and Barrett's oesophagus being considered risk factors. Reliable detection of Barrett's oesophagus during upper endoscopy is therefore mandatory but requires both endoscopy and histology for confirmation. Appropriate management of patients with endoscopic suspicion but negative on histology, or vice versa, or of patients with no endoscopic suspicion but with a biopsy diagnosis of intestinal metaplasia at the gastro-oesophageal junction, has not yet been studied prospectively. Patients and Methods: In a prospective multicentre study, 929 patients (51% male, mean age 50 years) referred for upper gastrointestinal endoscopy were included; 59% had reflux symptoms. The endoscopic aspect of the Z line and any suspicion of Barrett's oesophagus were noted, and biopsies were taken in all patients from the Z line (n = 4), gastric cardia (n = 2), and body and antrum (n = 2 each). Biopsies positive for specialised intestinal metaplasia (SIM) were reviewed by a reference pathologist for a final Barrett's oesophagus diagnosis. All patients with endoscopic and/or histological suspicion of Barrett's oesophagus were invited for a follow up endoscopy; the remaining cases (no endoscopic or histological suspicion of Barrett's oesophagus) were followed clinically. Results:Of 235 patients positive for Barrett's oesophagus on endoscopy and/or histology, 63% agreed to undergo repeat endoscopy (mean follow up period 30.5 months). 46% of patients with an endoscopic Barrett's oesophagus diagnosis but no histological confirmation (group A) showed the same distribution, a further 42% did not have Barrett's oesophagus, and 11% had confirmed Barrett's oesophagus on both endoscopy and biopsy on follow up. In the group with a histological Barrett's oesophagus diagnosis but negative on initial endoscopy (group B), follow up showed the same in 26% whereas 46% had no Barrett's oesophagus, and confirmed Barrett's oesophagus (endoscopy plus histology) was diagnosed in 17%. Of the study population, 16 patients had Barrett's oesophagus on initial endoscopy confirmed by histology which remained constant in 70% at follow up (group C). Of the remaining patients without an initial Barrett's oesophagus diagnosis on either endoscopy or histology (group D) and only clinical follow up (mean follow up period 38 months), one confirmed Barrett's oesophagus case was found among 100 patients re-endoscoped outside of the study protocol. However, no single case of dysplasia or cancer of the distal oesophagus was detected in any patient during the study period. Conclusions:Even in a specialised gastroenterology setting, reproducibility of presumptive endoscopic or histological diagnoses of Barrett's oesophagus at follow up were poor. Only 10-20% of cases with either endoscopic or histological suspicion of Barrett's oesophagus had established Barrett's oesophagus after 2.5 years of follow up. The risk of dysplasia in this population was very low and hence meticulous follow up may not be required.
ACCESSION #
14674380

 

Related Articles

  • Utilization of Cytokeratins 7 and 20 Does Not Differentiate between Barrett’s Esophagus and Gastric Cardiac Intestinal Metaplasia. Mohammed, I. A.; Streutker, C. J.; Riddell, R. H. // Modern Pathology;Jun2002, Vol. 15 Issue 6, p611 

    Long segment Barrett's esophagus (LSBE) is a recognized risk factor for the development of esophageal dysplasia and carcinoma. However, the risk of dysplasia arising within intestinal metaplasia below a normal-appearing Z-line (i.e., in native cardiac mucosa) is unknown. Regular endoscopic...

  • THE TRUE RISK OF BARRETT'S OESOPHAGUS--HAS IT BEEN UNDERESTIMATED? Kelty, C. J.; Gough, M. D.; van Wyk, Q.; Stephenson, T. J.; Ackroyd, R. // Gut;Apr2004 Supplement 3, Vol. 53, pA59 

    Barrett's oesophagus (BO) is the major risk factor for adenocarcinoma of the oesophagus, which is increasing in incidence more rapidly than any other cancer in the Western world. The risk of developing carcinoma in BO has been expressed in a number of different ways, for example from 30-125...

  • Understanding Barrett's oesophagus, part 1: Surveillance and management. Bailey, Karen // Gastrointestinal Nursing;Oct2009, Vol. 7 Issue 8, p28 

    Barrett's oesophagus is a condition that can predispose patients to the development of oesophageal cancer. Surveillance for this condition has the potential to detect early changes, although the value of endoscopic surveillance is debated. In the first of three articles exploring Barrett's...

  • Prevalence and risk factors for esophageal squamous cell cancer and precursor lesions in Anyang, China: a population-based endoscopic survey. He, Z.; Zhao, Y.; Guo, C.; Liu, Y.; Sun, M.; Liu, F.; Wang, X.; Guo, F.; Chen, K.; Gao, L.; Ning, T.; Pan, Y.; Li, Y.; Zhang, S.; Lu, C.; Wang, Z.; Cai, H.; Ke, Y. // British Journal of Cancer;9/28/2010, Vol. 103 Issue 7, p1085 

    Background:The etiology of esophageal squamous cell cancer (ESCC) in high prevalence regions of China remains unclear.Methods:Endoscopic biopsies were conducted among 7381 inhabitants aged from 25 to 65 of Anyang, China.Results:In this study, 2.57, 0.20 and 0.16% of the participants had mild,...

  • Risk of adenocarcinoma in Barrett's oesophagus: population based study. Gavin, Anna; Murray, Liam; Watson, Peter; Johnston, Brian; Sloan, James; Lal Mainie, Inder Mohan // BMJ: British Medical Journal (International Edition);9/6/2003, Vol. 327 Issue 7414, p534 

    This article investigates the risk of oesophageal malignancy in a large cohort of unselected patients with Barrett's oesophagus in Northern Ireland, where all incident cancers are routinely identified. We identified patients in the cohort and followed them up for death and oesophageal...

  • Extent of Low-Grade Dysplasia in Barrett's Esophagus: Is It Useful for Risk Stratification? Falk, Gary W.; Goldblum, John R. // American Journal of Gastroenterology;Mar2007, Vol. 102 Issue 3, p494 

    Low-grade dysplasia remains one of the great enigmas of Barrett's esophagus. Limited information is available on the natural history of this lesion, and studies suggest that cancer risk in patients with low-grade dysplasia is intermediate between that of intestinal metaplasia without dysplasia...

  • Treatment of Granular Cell Tumor of the Esophagus by Endoscopic Injection of Dehydrated Alcohol. Moreira, Liano Sia; Dani, Renato // American Journal of Gastroenterology;May1992, Vol. 87 Issue 5, p659 

    Granular cell tumor of the esophagus (GCFK) is a rare and mostly benign neoplasm. Its etiology is unknown and its histogenesis is uncertain. It is usually an incidental finding, detected during esophagogastroduo-denoscopy. In symptomatic cases, or when the lesions are more than I cm in diameter,...

  • Esophageal granular cell tumor: Clinical, endoscopic and histological features of 19 cases. MING ZHANG; ZE-QUN SUN; XIAO-PING ZOU // Oncology Letters;2014, Vol. 8 Issue 2, p551 

    Esophageal granular cell tumors (GCTs) are rare and often misdiagnosed. To demonstrate their clinicopathological features, the present study reports 19 cases and reviews the literature. There were 11 female and eight male esophageal GCT patients with a median age of 42.0 years. All the tumors...

  • Malignancy is the Most Common Cause of Gastric Outlet Obstruction in the Era of H2 Blockers. Shone, Dallas N.; Nikoomanesh, Parviz; Smith-Meek, Melissa M.; Bender, Jeffrey S. // American Journal of Gastroenterology;Oct1995, Vol. 90 Issue 10, p1769 

    Objectives: To determine the relative incidence of malignant and nonmalignant pathology in patients presenting with gastric outlet obstruction in the era of H2 blockers and to determine whether clinical features can differentiate between the two causes. Methods: The charts of 33 consecutive...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics